TSXV - Delayed Quote • CAD Telo Genomics Corp. (TELO.V) Follow Compare 0.1050 -0.0100 (-8.70%) At close: 3:07:52 PM EST Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for TELO.V 1D 5D -22.22% 1M -4.55% 3M -19.23% 6M -47.50% YTD -19.23% 1Y -36.36% 5Y -46.15% All -91.60% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: TELO.V View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Telo Genomics Closes Oversubscribed $2.5 Million Private Placement December 2024 TSX Penny Stocks With Growth Potential Telo Genomics Announces Private Placement for up to $2 Million Telo Genomics Receives Approval from the Intellectual Property Ontario Program (IPON) Discover 3 TSX Penny Stocks With Market Caps Over CA$4M Telo Genomics Expands its Strategic Collaboration with Mayo Clinic Telo Genomics Presents New Performance Data for Its Smoldering Myeloma Prognostic Test Telo Genomics Assessing MRD Status in TELO-DMRD Study Telo Genomics Receives CLIA Certification Telo Genomics Announces Its TeloViewSMM Test Is Accepted as Laboratory Developed Test by CAP Telo Genomics Presents Proprietary Artificial Intelligence Methodologies at ASCO 2024